Investor New Enterprise Associates 12, Limited Partnership
13D/G Filings

This page shows a list of all the recent 13D/G filings made by New Enterprise Associates 12, Limited Partnership . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-01-05 13D/A LQDA / Liquidia Corporation 2,525,572
2021-12-29 13D/A ARDX / Ardelyx, Inc. 13,656,482
2021-03-11 13D/A TRVN / Trevena, Inc. 4,811,691
2021-03-11 13D/A VIRX / Viracta Therapeutics, Inc.
2020-07-07 13D/A LQDA / Liquidia Corporation 2,525,572 2,525,572
2020-06-18 13D/A ARDX / Ardelyx, Inc. 16,736,044 13,656,482
2019-12-06 13D/A YMTX / Yumanity Therapeutics Inc 5,634,037
2018-08-06 13D LQDA / Liquidia Corporation 2,525,572
2018-06-05 13D/A ARDX / Ardelyx, Inc. 15,486,044 16,736,044
2018-03-06 13D/A TNTR / Tintri, Inc. 6,219,583
2018-01-10 13G/A ZSAN / Zosano Pharma Corp 2,052,810
2017-12-21 13D/A YMTX / Yumanity Therapeutics Inc 3,568,690 5,634,037
2017-08-11 13D/A GRPN / Groupon, Inc. 21,370,995
2017-07-13 13D TNTR / Tintri, Inc. 5,248,359
2017-02-13 13G/A ZSAN / Zosano Pharma Corp 2,158,539 2,052,810
2016-09-20 13D/A YMTX / Yumanity Therapeutics Inc 3,096,592 3,568,690
2016-08-12 13D/A GRPN / Groupon, Inc. 33,986,017 21,370,995
2016-07-28 13D/A ARDX / Ardelyx, Inc. 13,194,501 15,486,044
2016-06-16 13G/A OPWR / Opower, Inc.
2016-06-10 13D/A GRPN / Groupon, Inc. 44,169,506 33,986,017
2016-04-15 13D GRPN / Groupon, Inc. 44,161,965 44,169,506
2016-04-08 13D/A TRIV / TriVascular Technologies, Inc. 3,999,100
2016-02-26 13D YMTX / Yumanity Therapeutics Inc 3,096,592
2016-02-10 13G/A GRPN / Groupon, Inc. 44,161,965
2016-02-05 13G ZSAN / Zosano Pharma Corp 2,158,539
2016-01-21 13D/A ARDX / Ardelyx, Inc. 11,694,501 13,194,501
2016-01-07 13D/A VIRX / Viracta Therapeutics, Inc. 7,789,644
2015-12-17 13D/A TRVN / Trevena, Inc. 4,811,691
2015-11-05 13D/A TRIV / TriVascular Technologies, Inc. 3,999,100
2015-06-15 13D/A ARDX / Ardelyx, Inc. 11,694,501
2015-05-11 13D/A HPTX / Hyperion Therapeutics Inc 2,384,221
2015-04-07 13D/A HPTX / Hyperion Therapeutics Inc 2,384,221
2015-02-11 13G/A GRPN / Groupon, Inc. 44,129,713
2015-02-09 13G OPWR / Opower, Inc. 8,989,766
2015-02-03 13G/A ECOM / ChannelAdvisor Corp
2015-02-03 13G/A FIO / Franklin Income Opportunities Fund
2015-02-03 13G/A WDAY / Workday, Inc.
2014-12-18 13D/A ARDX / Ardelyx, Inc. 5,629,734
2014-12-15 13D/A TRVN / Trevena, Inc. 4,811,691
2014-11-04 13D/A PRTK / Paratek Pharmaceuticals Inc.
2014-07-01 13D ARDX / Ardelyx, Inc. 6,619,734
2014-04-28 13D TRIV / TriVascular Technologies, Inc. 3,999,100
2014-02-21 13G/A GRPN / Groupon, Inc. 54,265,656
2014-02-12 13G/A WDAY / Workday, Inc. 4,652,736
2014-02-12 13G/A FIO / Franklin Income Opportunities Fund 7,155,879
2014-02-12 13D TRVN / Trevena, Inc. 3,811,691
2014-02-12 13G/A GRPN / Groupon, Inc. 54,246,515
2014-01-31 13G ECOM / ChannelAdvisor Corp 2,628,733
2013-02-13 13G WDAY / Workday, Inc. 13,927,273
2013-02-13 13G/A FIO / Franklin Income Opportunities Fund 7,113,379
2013-02-13 13G/A ECHO / Echo Global Logistics Inc
2013-02-13 13G/A GRPN / Groupon, Inc. 87,200,376
2012-08-07 13D HPTX / Hyperion Therapeutics Inc 2,884,221
2012-02-13 13G FIO / Franklin Income Opportunities Fund 23,648,596
2012-02-13 13G GRPN / Groupon, Inc. 87,184,956